ESTUDIO CONTROLADO, ALEATORIZADO Y DOBLE CIEGO DE TENOFOVIR DF FRENTE A DEFOVIR DIPIVOXIL PARA EL TRATAMIENTO DE LA HEPATITIS B CRONICA CON POSIBLE MUTACION DEL PRENUCLEO

Datos básicos

Código:
GS-US-174-0102
Protocolo:
GS-US-174-0102
EUDRACT:
2004-005119-27
NCT:
Centro:
HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
Dotación:
Año de incio:
Año de finalización:
ENSAYO CLÍNICO

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

GILEAD SCIENCES INC

Resultados del Ensayo Clínico


A Century of Progress on Wilson Disease and the Enduring Challenges of Genetics, Diagnosis, and Treatment.

Penning, Louis C.; (...); Weiskirchen, Ralf

Article. 10.3390/biomedicines11020420. 2023

  • Open Access.

Access to liver transplant for women in Spain: a national registry analysis

Tejedor Bravo, Marta; (...); Berenguer, Marina

Meeting Abstract. 2023


Access to liver transplant for women in Spain: a national registry analysis

Tejedor, M.; (...); Berenguer, M.

Meeting Abstract. 2023


Addressing the Burden and Management Strategies for Disparities and Inequities Among Liver Transplant Professionals: The ILTS Experience.

Andacoglu, Oya; (...); Selzner, Nazia

Article. 10.3389/ti.2023.11240. 2023

  • Open Access.

Anesthesia and Critical Care for the Prediction and Prevention for Small-for-size Syndrome: Guidelines from the ILTS-iLDLT-LTSI Consensus Conference.

Chadha, Ryan; (...); Rela, Mohamed

Article. 10.1097/TP.0000000000004803. 2023


Are MELD and MELDNa Still Reliable Tools to Predict Mortality on the Liver Transplant Waiting List?

Tejedor, Marta, Selzner, Nazia, Berenguer, Marina

Article. 10.1097/TP.0000000000004163. 2022

  • Open Access.

Brain abscesses in early post-liver transplantation.

Mínguez Sabater A; (...); Prieto Castillo M

Case Reports. 10.1016/j.eimc.2021.02.002. 2021


Brain abscesses in early post-liver transplantation.

Minguez Sabater, Alejandro; (...); Prieto Castillo, Martin

Article. 10.1016/j.eimce.2021.09.007. 2021


Can endothelial biomarkers before liver transplantation together with classical cardiovasculat risk factors be useful to predict cardiovascular risk after liver transplantation

Herreras Lopez, Julia; (...); Aguilera Sancho, Victoria

Meeting Abstract. 2022


Can endothelial biomarkers before LT together with classical cardiovascular risk factors be useful to predict cardiovascular risk after LT?

Herreras, J.; (...); Aguilera, V.

Article. 2022


Circulating MicroRNAs: Dynamic Markers of Liver Transplant Injury.

Mas VR, Bardhi E, Berenguer M

Article. 10.1097/TP.0000000000003816. 2021

  • Open Access.

Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease.

Simao, Andre Lopes; (...); Castro, Rui E

Article. 10.1016/j.jhepr.2023.100697. 2023

  • Open Access.

CMV reactivation (rCMV) is associated with lower hepatocellular carcinoma (HCC) recurrence after liver transplatatoin (LT)

Aguilera, V.; (...); Berenguer, M.

Meeting Abstract. 2023


CMV reactivation after liver transplantation (LT) in HIV infected is similar to non-HIV patients: a single center comparative study

Garcia-Garcia, Sonia; (...); Aguilera Sancho, Victoria

Meeting Abstract. 2023


CMV reactivation is associated with lower hepatocellular carcinoma (HCC) recurrence after liver transplantation (LT)

Aguilera Sancho, Victoria; (...); Berenguer, Marina

Meeting Abstract. 2022


COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External Controls.

Kowdley KV; (...); Villamil A

Article. 10.14309/ajg.0000000000003029. 2024

  • Open Access.

Comprehensive analysis and insights gained from long-term experience of the Spanish DILI registry.

Stephens C; (...); Andrade RJ

Article. 10.1016/j.jhep.2021.01.029. 2021

  • Open Access.

Correction to COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External Controls.

Kowdley, Kris V; (...); Villamil, Alejandra

Article. 10.14309/ajg.0000000000003153. 2024

  • Open Access.

Corrigendum to "Alcoholic and Nonalcoholic Liver Disease: Diagnostic Assessment and Therapeutic Perspectives".

Gitt S; (...); Berenguer M

Correction. 10.1155/2020/4305190. 2020

  • Open Access.

COVID vaccination among liver transplant recipients: A EASL-ESOT/ELITA-ILTS multi society survey

Vinaixa, Carmen; (...); Berenguer, Marina

Meeting Abstract. 2022


COVID vaccination among liver transplant recipients: an EASL-ESOT/ELITA-ILTS multi-society international survey

Vinaixa, C.; (...); Berenguer, M.

Meeting Abstract. 2022


Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation

Rodriguez-Peralvarez, Manuel; (...); Gomez Bravo, Miguel Angel

Meeting Abstract. 2022

  • Open Access.

Cytomegalovirus reactivation is associated with lower hepatocelullar carcinoma recurrence rates after liver transplantation

Aguilera Sancho, Victoria; (...); Rodriguez-Peralvarez, Manuel

Meeting Abstract. 2023


CYTOMEGALOVIRUS SPECIFIC POLYFUNCTIONAL T-CELL RESPONSES EXPRESSING CD107A ASSOCIATED WITH CONTROL OF CMV REACTIVATION AFTER LIVER TRANSPLANTATION

Carvalho-Gomes, A; (...); Aguilera, V

Meeting Abstract. 2021


Cytomegalovirus specific polyfunctional T-cell responses expressing CD107a predict control of CMV infection after liver transplantation.

Carvalho-Gomes Â; (...); López-Labrador FX

Article. 10.1016/j.cellimm.2021.104455. 2022

  • Open Access.

Cytomegalovirus specific polyfunctional T-cells control CMV reactivation after liver transplantation

Carvalho-Gomes, A; (...); Aguilera, V

Meeting Abstract. 2021


Cytomegalovirus specific polyfunctional t-cells control CMV reactivation, after liver transplantation

Carvalho-Gomes, Angela; (...); Sancho, Victoria Aguilera

Meeting Abstract. 2024


Characteristics and impact of sex in a cohort of patients with primary sclerosing cholangitis: Experience of a transplant center in the Mediterranean basin.

Mínguez Sabater A; (...); Berenguer, Marina

Article. 10.1016/j.gastrohep.2021.03.017. 2022


CHARACTERISTICS AND IMPACT OF SEX IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS: A MULTICENTER STUDY FROM A CLASSICALLY LOW PREVALENCE AREA

Minguez, Alejandro; (...); Berenguer, Marina

Meeting Abstract. 2021


Characteristics and trends of liver transplantation in a cohort of patients with primary sclerosing cholangitis: a retrospective multicenter study

Minguez, A.; (...); Berenguer, M.

Meeting Abstract. 2022


Characteristics, trends and outcomes of liver transplantation (LT) for primary sclerosing cholangitis (PSC) in female patients: analysis of the European Liver Transplantation Registry (ELTR)

Di Maira, T; (...); European Liver & Intestine

Meeting Abstract. 2021


Characteristics, Trends, and Outcomes of Liver Transplantation for Primary Sclerosing Cholangitis in Female Versus Male Patients: An Analysis From the European Liver Transplant Registry

Berenguer M; (...); European Liver Intestine Transplan

Article. 10.1097/TP.0000000000003542. 2021


Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis (vol 22, pg 2062, 2024)

De Vincentis, A.; (...); Conde, Isabel

Correction. 2025


Development and validation of a scoring system to predict response to obeticholic acid in primary biliary cholangitis.

De Vincentis, Antonio; (...); Carbone, Marco

Article. 10.1016/j.cgh.2024.05.008. 2024


Does colectomy improve survival in patients with ulcerative colitis undergoing liver transplant for autoimmune liver diseases?

Trapero-Marugan, M.; (...); Cuervas-Mons, V.

Meeting Abstract. 2023


Early liver transplantation for acute alcoholic hepatitis In a spanish liver transplant center

Aguilera Sancho, Victoria; (...); Berenguer, Marina

Meeting Abstract. 2023


Early predictors of corticosteroid response in acute severe autoimmune hepatitis: A nationwide multicenter study

Tellez, Luis; (...); Albillos, Agustin

Article. 10.1111/apt.16926. 2022

  • Open Access.

Economic Impact of European Liver and Intestine Transplantation Association (ELITA) Recommendations for Hepatitis B Prophylaxis After Liver Transplantation.

Cortesi, Paolo Angelo; (...); Belli, Luca Saverio

Article. 10.3389/ti.2023.10954. 2023

  • Open Access.

EFFECTIVENESS AND SAFETY OF SECOND-LINE THERAPY IN PRIMARY BILIARY CHOLANGITIS (PBC): A PROSPECTIVE MULTICENTER REAL-WORLD COHORT

Gomez-Dominguez, Elena; (...); Fernandez-Rodriguez, Conrado

Meeting Abstract. 2023


EFFICACY OF OBETICHOLIC ACID (OCA) VS PLACEBO AND EXTERNAL CONTROL (EC) ON CLINICAL OUTCOMES IN PRIMARY BILIARY CHOLANGITIS (PBC)

Kowdley, Kris V.; (...); Villamil, Alejandra

Meeting Abstract. 2023


Enhanced recovery after surgery programs improve short-term outcomes after liver transplantation-A systematic review and meta-analysis

Tinguely, Pascale; (...); Spiro, Michael

Article. 10.1111/ctr.14453. 2021


Enhanced recovery for liver transplantation: recommendations from the 2022 International Liver Transplantation Society consensus conference.

Pollok, Joerg M.; (...); Spiro, Michael

Article. 10.1016/S2468-1253(22)00268-0. 2023


ESOT Consensus Platform for Organ Transplantation: Setting the Stage for a Rigorous, Regularly Updated Development Process.

Cillo U; (...); Selzner N

Review. 10.3389/ti.2022.10915. 2022

  • Open Access.

European Society for Organ Transplantation Consensus Statement on Biomarkers in Liver Transplantation.

Berenguer M; (...); Zubair H

Article. 10.3389/ti.2023.11358. 2023

  • Open Access.

Everolimus plus minimized tacrolimus on kidney function in liver transplantation: REDUCE, a prospective, randomized controlled study.

Gómez-Bravo M; (...); Santoyo J

Article. 10.17235/reed.2022.8549/2021. 2022

  • Open Access.

Excess waitlist mortality and survival benefit of liver transplantation for patients with severe acute-on-chronic liver failure: Interim results of the CHANCE study

Gustot, Thierry; (...); Jalan, Rajiv

Meeting Abstract. 2024


Exchangeable copper for patients with Wilson disease at follow-up: rethinking normal ranges or changing methodology.

Marino, Zoe; (...); Berenguer, Marina

Article. 10.1097/HEP.0000000000001105. 2024

  • Open Access.

EXCHANGEABLE COPPER QUANTIFICATION FELLS BELOW NORMAL RANGE IN A HIGH PROPORTION OF PATIENTS WITH WILSON DISEASE DURING FOLLOW-UP

Mendez, Zoe Marino; (...); Berenguer, Marina

Meeting Abstract. 2024


Exchangeable copper quantification fells belownormal range in a high proportion of patients withWilson disease during follow-up

Marino, Zoe; (...); Berenguer, Marina

Meeting Abstract. 2024


EXPERT CONSENSUS CRITERIA AND PRACTICAL RECOMMENDATIONS FOR PBC CARE IN THE COVID-19 ERA AND BEYOND

Berenguer, Marina; (...); Carbone, Marco

Meeting Abstract. 2021


Exploring pregnancy, breastfeeding and contraception among women with Wilson disease in Spain: results from the Spanish Wilson registry

Romero-Gutierrez, Marta; (...); Marino, Zoe

Meeting Abstract. 2023


External validation of models to predict hepatocellular carcinoma (HCC) in HCV SVR F3-F4 patients

Sahuco, Ivan; (...); Berenguer, Marina

Meeting Abstract. 2023


External validation of models to predict hepatocellular carcinoma in Hepatitis C Virus cured F3-F4 patients.

Carvalho-Gomes Â; (...); Berenguer M

Article. 10.1002/ueg2.12571. 2024

  • Open Access.

Fat, cancer, the gut-liver axis and rare liver diseases

Berenguer, Marina

Editorial Material. 2020

  • Open Access.

Fat, cancer, the gut-liver axis and rare liver diseases.

Berenguer M

Editorial Material. 10.1016/j.jhepr.2020.100189. 2020

  • Open Access.

FibroScan compared to liver biopsy for accurately detecting recurrent hepatic steatosis and fibrosis after liver transplantation for metabolic dysfunction-associated steatohepatitis

Martinez-Arenas, Laura; (...); Berenguer, Marina

Meeting Abstract. 2024


FibroScan compared to liver biopsy for accurately detecting recurrent hepatic steatosis and fibrosis after liver transplantation for metabolic dysfunction-associated steatohepatitis

Martinez-Arenas, L.; (...); Berenguer, M.

Meeting Abstract. 2024


FibroScan compared to liver biopsy for accurately staging recurrent hepatic steatosis and fibrosis after transplantation for MASH.

Martinez-Arenas, Laura; (...); Berenguer, Marina

Article. 10.1111/liv.16085. 2024

  • Open Access.

First nationwide genetic study on Wilson disease (Spanish Wilson registry): high diversity in mutations and in use of genetic evaluation, association with clinical data and influence on diagnosis and health costs

Alonso Castellano, Pablo; (...); Garcia-Villarreal, Luis

Meeting Abstract. 2023


Frailty and Sarcopenia in Acute-on-Chronic Liver Failure

Renau, LP; (...); Berenguer M

Article. 10.1002/hep4.1722. 2021

  • Open Access.

Frailty changes after liver transplantation in the Spanish setting. Results from a Spanish multicentre prospective cohort study

Puchades, L.; (...); Berenguer, M.

Meeting Abstract. 2023


Frailty Changes After Liver Transplantation. Results From a Spanish Multicenter Prospective Cohort Study

Puchades, Lorena; (...); Berenguer, Marina

Article. 10.1097/TXD.0000000000001599. 2024

  • Open Access.

GENDER AND RACIAL DISCRIMINATION AMONG LIVER TRANSPLANTATION PROFESSIONALS: A SURVEY FROM ILTS EDI COMMITTEE

Andacoglu, Oya; (...); Selzner, Nazia

Meeting Abstract. 2021


Gender and racial discrimination among liver transplantation professionals: report of a global survey

Aguilera, V.; (...); Selzner, N.

Article. 2022


Gender and Racial Disparity Among Liver Transplantation Professionals: Report of a Global Survey

Aguilera, Victoria; (...); Selzner, Nazia

Article. 10.3389/ti.2022.10506. 2022

  • Open Access.

Gender differences in liver transplantation (LT) for acute liver failure (ALF) in a multicentre ALF-LT Spanish cohort

Conde, Isabel; (...); Aguilera Sancho, Victoria

Meeting Abstract. 2023


Gender differences in liver transplantation (LT) for acute liver failure (ALF) in a multicentre ALF-LT Spanish cohort

Conde, I.; (...); Aguilera, V.

Meeting Abstract. 2023


Good posttransplant outcome using donors after cardiac death (DCD) when applying strict selection criteria

de la Varga, MF; (...); Castillo, MP

Meeting Abstract. 2021


Good post-transplant outcomes using liver donors after circulatory death when applying strict selection criteria: A propensity-score matched-cohort study.

Fernandez-de la Varga, Margarita; (...); Aguilera, Victoria

Article. 10.1016/j.aohep.2022.100724. 2022

  • Open Access.

Health-Related Quality of Life in Patients Living with Wilson Disease in Spain: A Cross-Sectional Observational Study.

Marino, Zoe; (...); Anguera, Anna

Article. 10.3390/jcm12144823. 2023

  • Open Access.

Heat stroke and fulminant hepatitis: Conservative management or liver transplant?

Ladrón Abia P; (...); Berenguer Haym MC

Letter. 10.1016/j.gastrohep.2020.11.004. 2021


Hepatic nerve endings are rewired by cholestatic injury to connect inflamed lymphatics to sites of ductular remodelling

Noon, Luke; (...); Lloyd, Alison

Meeting Abstract. 2023


Hepatic steatosis and steatohepatitis: a functional meta-analysis of sex-based differences in transcriptomic studies

Catala-Senent, Jose F.; (...); Garcia-Garcia, Francisco

Article. 10.1186/s13293-021-00368-1. 2021

  • Open Access.

HepatoPredict Accurately Selects Hepatocellular Carcinoma Patients for Liver Transplantation Regardless of Tumor Heterogeneity

Andrade, Rita; (...); Cardoso, Joana

Article. 10.3390/cancers17030500. 2025

  • Open Access.

Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: an updated EASL position paper.

Marjot, Thomas; (...); Cornberg, Markus

Article. 10.1016/j.jhep.2022.07.008. 2022

  • Open Access.

Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteria

Beumer, Berend R.; (...); IJzermans, Jan N. M.

Article. 10.1002/jcsm.13053. 2022

  • Open Access.

Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteria

Beumer, Berend; (...); Ijzermans, Jan

Meeting Abstract. 10.1002/jcsm.13053. 2022


Impact of suffering Wilson disease in Spain: an observational cross-sectional multicenter study

Marino, Zoe; (...); Anguera, Anna

Meeting Abstract. 2023


Incidence and prognostic impact of cancer after liver transplantation

Gastaca, M; (...); Rodriguez-Peralvarez, M

Meeting Abstract. 2021


Incidence of de novo tumors after liver transplantation (LT) in HIV infected is similar to non-HIV patients: a single center comparative study

Chafer, Isabel Terol; (...); Sancho, Victoria Aguilera

Meeting Abstract. 2023


Incidence of de novo tumors after liver transplantation (LT) in HIV infected is similar to non-HIV patients: a single center comparative study

Chafer, I. Terol; (...); Sancho-Tello, M. V. Aguilera

Meeting Abstract. 2023


International Liver Transplantation Society Global Census report: a first look at the pediatric liver transplantation activity around the world

Lopez-Verdugo, F; (...); Pediat Liver Transplantation

Meeting Abstract. 2021


International Living Donor Liver Transplant Registry - Initial progress towards transparent reporting of outcomes

Kantsedikas, I.; (...); Rela, M.

Meeting Abstract. 2024


LATTICE radiotherapy: A one institution experience

Solero, I.; (...); Conde, A.

Meeting Abstract. 2023


Launch of the International Living Donor Liver Transplantation Outcomes Registry.

Staubli, Sebastian; (...); Rela, Mohamed

Letter. 10.1016/S2468-1253(23)00185-1. 2023


Lessons from population genomics for Wilson disease: Prevalence, penetrance of mutations, clinical implications and design of regional screening programmes

Alonso Castellano, Pablo; (...); Garcia-Villarreal, Luis

Meeting Abstract. 2023


Liver Transplantation 2023: Status Report, Current and Future Challenges.

Terrault, Norah A; (...); Heimbach, Julie

Article. 10.1016/j.cgh.2023.04.005. 2023

  • Open Access.

LIVER TRANSPLANTATION FOR NON-ALCOHOLIC STEATOHEPATITIS: LOW PREVALENCE REGIONS ARE CATCHING UP

Martinez Arenas, Laura; (...); Berenguer, Marina

Meeting Abstract. 2022


Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: Results of the ELITA/EF-CLIF collaborative study (ECLIS)

Belli, LS; (...); ELITA EF-CLIF Working Grp

Article. 10.1016/j.jhep.2021.03.030. 2021

  • Open Access.

LOCATION AND ALLOCATION: INEQUITY OF ACCESS TO LIVER TRANSPLANTATION FOR PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE GRADE 3 (ACLF-3) ACROSS EUROPE.

Artzner, Thierry; (...); Jalan, Rajiv

Meeting Abstract. 2021


Location and allocation: inequity of access to liver transplantation for patients with severe acute-on-chronic liver failure in Europe.

Artzner, Thierry; (...); Jalan, Rajiv

Article. 10.1002/lt.26499. 2022

  • Open Access.

Long term follow-up in HCV infected patients with end stage chronic kidney disease after DAA therapy

Martinez-Camprecios, J; (...); Buti, M

Meeting Abstract. 2021


Longitudinal outcomes of obeticholic acid therapy in ursodiol-nonresponsive primary biliary cholangitis: Stratifying the impact of add-on fibrates in real-world practice.

Gomez, E; (...); Fernandez-Rodriguez, C M

Article. 10.1111/apt.18004. 2024

  • Open Access.

Long-Term Effectiveness, Safety, and Patient- Reported Outcomes of Self-Administered Subcutaneous Hepatitis B Immunoglobulin in Liver Post-Transplant Hepatitis B Prophylaxis: A Prospective Non-Interventional Study

Roche B; (...); Samuel D

Article. 10.12659/AOT.936162. 2022

  • Open Access.

Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy

Martinez-Camprecios, Joan; (...); Buti, Maria

Article. 10.1016/j.gastrohep.2022.12.004. 2023


Long-term outcome after living donor liver transplantation compared to donation after brain death in autoimmune liver diseases: Experience from the European Liver Transplant Registry.

Heinemann M; (...); all the other contributing centers (www.eltr.org) and the European Liver and Int

Article. 10.1111/ajt.16864. 2022

  • Open Access.

Long-term prospective follow-up of a primary biliary cholangitis (PBC) multicenter cohort treated with Obeticholic Acid (OCA). Interaction effect of triple therapy with fibrates

Gomez-Dominguez, Elena; (...); Fernandez-Rodriguez, Conrado

Meeting Abstract. 2023


Long-term survival after living donor liver transplantation in primary sclerosing cholangitis

Liwinski, T; (...); Schramm, C

Meeting Abstract. 2021


Low penetrance of frequent ATP7B mutations explains the low prevalence of Wilson disease. Lessons from real-life registries.

Alonso-Castellano, Pablo; (...); Garcia-Villarreal, Luis

Article. 10.1016/j.dld.2024.09.002. 2024


Main clinical characteristics and evolutionary events among patients suffering Wilson disease in Spain: first results from the Spanish Wilson registry

Marino, Zoe; (...); Castillo, Pilar

Meeting Abstract. 2023


Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update.

Ruiz-Arabi, Elisa; (...); Aguado, Jose Maria

Article. 10.1016/j.trre.2024.100875. 2024

  • Open Access.

Management of Established Small-for-size Syndrome in Post Living Donor Liver Transplantation: Medical, Radiological, and Surgical Interventions: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference.

Kirchner, Varvara A.; (...); Rela, Mohamed

Article. 10.1097/TP.0000000000004771. 2023


Metabolic syndrome before liver transplantation: does it have an impact on post liver transplantation outcomes?

Herreras Lopez, Julia; (...); Aguilera, Victoria

Article. 10.17235/reed.2022.8384/2021. 2022

  • Open Access.

Mitochondrial bioenergetics boost macrophages activation promoting liver regeneration in metabolically compromised animals.

Goikoetxea-Usandizaga, Naroa; (...); Martínez-Chantar ML

Article. 10.1002/hep.32149. 2021

  • Open Access.

MORE THAN A THIRD OF UNTREATED PATIENTS WITH CHRONIC HEPATITIS DELTA HAVE A DECREASE OR REACH UNDETECTABLE LEVELS OF HDV-RNA DURING NATURAL HISTORY

Palom, A; (...); Ferret, MAB

Meeting Abstract. 2020


Mortality and Causes of Death After Liver Transplantation: Analysis of Sex Differences in a Large Nationwide Cohort.

Serrano MT; (...); Salcedo M

Article. 10.3389/ti.2022.10263. 2022

  • Open Access.

mTOR inhibitors a potential predisposing factor for chronic hepatitis E: Results from the prospective collaborative CHES study (Chronic Hepatitis EScreening in patients with immune impairment and increased transaminases levels).

Riveiro-Barciela, Mar; (...); Esteban, Rafael

Article. 10.1016/j.gastrohep.2023.01.010. 2023


Multidrug resistant bacterial infections after liver transplantation: prevalence, impact and associated risk factors

Martin-Mateos, Rosa; (...); Albillos, Agustin

Meeting Abstract. 2022


Multidrug-resistant bacterial infections after liver transplantation: prevalence, impact, and risk factors

Martin-Mateos, R.; (...); Albillos, A.

Meeting Abstract. 2024


Multidrug-resistant bacterial infections after liver transplantation: prevalence, impact, and risk factors.

Martin-Mateos R; (...); Albillos A

Article. 10.1016/j.jhep.2024.02.023. 2024


Multi-institutional Analysis of Metastasis-directed Therapy with or Without Androgen Deprivation Therapy in Oligometastatic Castration-sensitive Prostate Cancer.

Deek MP; (...); Sweeney C

Article. 10.1016/j.euo.2024.03.010. 2024

  • Open Access.

New ERAS in liver transplantation - Past, present, and next steps

Hannon, Vivienne N.; (...); ERAS4OLT Org Working Grp

Article. 10.1111/ctr.14625. 2022


Non-alcoholic steatohepatitis as liver transplant indication: similarities and differences between a high and a low prevalence countries

Martinez-Arenas, L.; (...); Berenguer, M.

Meeting Abstract. 2022


Non-alcoholic steatohepatitis is also becoming a major liver transplant indication in Spain, a historically low risk area

Martinez-Arenas, Laura; (...); Berenguer, Marina

Meeting Abstract. 2022


Nutritional status in hepatic encephalopathy and transjugular intrahepatic portosystemic shunt-TIPS, and strategies to improve the outcomes

Berenguer, M.

Review. 10.51821/86.2.11430. 2023

  • Open Access.

Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study.

Reig, A; (...); Pares, A

Article. 10.14309/ajg.0000000000001343. 2021

  • Open Access.

One-quarter of chronic hepatitis D patients reach HDV-RNA decline or undetectability during the natural course of the disease

Palom, A; (...); Buti, M

Article. 10.1111/apt.16485. 2021


Optimal management of perioperative analgesia regarding immediate and short-term outcomes after liver transplantation - A systematic review, meta-analysis and expert panel recommendations

Sun, Li-Ying; (...); ERAS4OLT Org Working Grp

Review. 10.1111/ctr.14640. 2022


Optimization of treatment in patients with primary biliary cholangitis: Gamma-glutamyl transferase levels as an early prognostic marker for ursodeoxycholic acid response. Results from the ColHai registry

Fernandez-Gordon Sanchez, Flor M.; (...); Gomez-Dominguez, Elena

Meeting Abstract. 2024


OVERCOMING BARRIERS TO CARE FOR DELTA INFECTED PATIENTS

Carvalho-Gomes, Angela; (...); Berenguer, Marina

Meeting Abstract. 2022


Overcoming barriers to care for Delta infected patients

Bono, Ariadna; (...); Berenguer, Marina

Meeting Abstract. 2023


Overview of Cellular and Soluble Mediators in Systemic Inflammation Associated with Non-Alcoholic Fatty Liver Disease.

Marques, Patrice; (...); Sanz, Maria-Jesus

Article. 10.3390/ijms24032313. 2023

  • Open Access.

Paediatric solid organ transplant recipients (SOTR) demonstrate greater serological response to initial SARS-CoV-2 vaccination than adult SOTR, and comparable rates of antibody degradation

Pilar Ballester, Maria; (...); Nicastro, Emanuele

Meeting Abstract. 2024


PHYSICAL FRAILTY IN LIVER TRANSPLANTATION.

Puchades Renau L; (...); Berenguer Haym M

Review. 10.17235/reed.2020.7448/2020. 2021

  • Open Access.

Post Living Donor Liver Transplantation Small-for-size Syndrome: Definitions, Timelines, Biochemical, and Clinical Factors for Diagnosis: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference.

Kow, Alfred Wei Chieh; (...); Ikegami, Toru

Article. 10.1097/TP.0000000000004770. 2023


PREDICTION OF BIOCHEMICAL RESPONSE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS TREATED WITH OBETICHOLIC ACID: DERIVATION AND EXTERNAL VALIDATION OF THE OCA RESPONSE SCORE (ORS)

De Vincentis, Antonio; (...); Carbone, Marco

Meeting Abstract. 2023


Predictive factors for decompensating events in patients with cirrhosis with primary biliary cholangitis under different lines of therapy.

Ampuero J; (...); Fernández-Rodríguez C

Article. 10.1097/HEP.0000000000000826. 2024


Preventing Small-for-size Syndrome in Living Donor Liver Transplantation: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference.

Hakeem AR; (...); Rela M

Article. 10.1097/TP.0000000000004769. 2023


Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2022 Clinical Practice Guideline.

Awan, Ahmed Arslan Yousuf; (...); Jadoul, Michel

Article. 10.7326/M23-2391. 2023

  • Open Access.

Primary biliary cholangitis and SARS-CoV-2 infection: incidence, susceptibility and outcomes.

Ampuero J; (...); Molina E

Letter. 10.1136/gutjnl-2021-325700. 2021

  • Open Access.

Primary sclerosing cholangitis as an indication for liver transplantation. Results and conditioning factors: relationship with associated intestinal pathology

Fernandez, Ainhoa; (...); Salcedo, Magdalena

Meeting Abstract. 2023


Primary Sclerosing Cholangitis: Gender Effects in Valencia's Low-Prevalence Region.

Minguez, Alejandro; (...); Berenguer, Marina

Article. 10.1007/s10620-024-08368-y. 2024


Profile of plasma microRNAs as a potential biomarker of Wilson's disease.

Sanchez-Monteagudo, Ana; (...); Espinos, Carmen

Article. 10.1007/s00535-024-02135-6. 2024

  • Open Access.

Prognosticating hepatocellular carcinoma before and after liver transplantation with HepatoPredict

Silva, Silvia Gomes; (...); Cardoso, Joana

Meeting Abstract. 2024


Protocol for an International Living Donor Liver Transplant Registry ! LDLTregistry.org

Turner, B.; (...); Salinas, C. Hidalgo

Meeting Abstract. 2023


Recommendations for the integral diagnosis of chronic viral hepatitis in a single analytical extraction.

Crespo, Javier; (...); Calleja, Jose Luis

Practice Guideline. 10.1016/j.gastrohep.2022.09.009. 2023


Re-irradiation in NSCLC High-dose RT: Control, Survival and Toxicity

Germain, J.; (...); Conde, A.

Meeting Abstract. 2023


Reproductive and pregnancy control in Wilson disease patients in Spain.

Romero-Gutiérrez M; (...); Mariño Z

Article. 10.1097/MEG.0000000000002831. 2024


Rising indication of non-alcoholic steatohepatitis as transplant indication in historically low risk areas

Martinez-Arenas, L.; (...); Berenguer, M.

Meeting Abstract. 2022


Risk of decompensated cirrhosis in patients with primary biliary cholangitis under first, second and third-line therapies

Lucena, Ana; (...); Ampuero, Javier

Meeting Abstract. 2023


Rivaroxaban improves survival and decompensation in cirrhotic patients with moderate liver dysfunction. Double-blind, placebocontrolled trial

Puente Sanchez, Angela; (...); Garcia Pagan, Juan Carlos

Meeting Abstract. 2023


Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant.

Mehta, Gautam; (...); Jalan, Rajiv

Article. 10.1097/HC9.0000000000000273. 2023

  • Open Access.

Should we seek complete liver tests normalization in primary biliary cholangitis? Data from ColHai registry

Diaz-Gonzalez, Alvaro; (...); del Registro, Grupo

Meeting Abstract. 2022


Significant heterogeneity in the diagnosis and long-term management of Wilson disease: Results from a large multicenter Spanish study

Berenguer, Marina; (...); GEMHEP

Article. 10.1016/j.gastrohep.2022.10.018. 2023


SIMILAR POST-TRANSPLANT OUTCOMES USING DONORS AFTER CARDIAC DEATH WHEN APPLYING STRICT SELECTION CRITERIA

de la Varga, MF; (...); Aguilera, V

Meeting Abstract. 2021


Similar rates of liver transplantation (LT) for acute liver failure (ALF) but changes in patient profiles in a Spanish multicentre cohort

Conde, I.; (...); Aguilera, V.

Meeting Abstract. 2023


Simple score to assess cardiovascular risk post-liver transplantation

Di Maira, T; (...); Berenguer, M

Meeting Abstract. 2021


SIMPLE SCORE TO ASSESS CARDIOVASCULAR RISK POST-LIVER TRANSPLANTATION

Di Maira, Tommaso; (...); Berenguer, Marina

Meeting Abstract. 2022


Survey to evaluate the implementation of the recommendations on the comprehensive diagnosis of viral hepatitis in a single extraction: where are we?

Cabezas, Joaquin; (...); Crespo, Javier

Meeting Abstract. 2023


SURVEY TO EVALUATE THE IMPLEMENTATION OF THE RECOMMENDATIONS ON THE COMPREHENSIVE DIAGNOSIS OF VIRAL HEPATITIS IN A SINGLE EXTRACTION: WHERE ARE WE?

Cabezas, Joaquin; (...); Crespo Garcia, Javier

Meeting Abstract. 2023


The concentration of HDV-RNA correlates with the probability of developing clinical events in patients with chronic hepatitis D

Palom, Adriana; (...); Buti, Maria

Meeting Abstract. 2024


The global prospective observational study to evaluate the role of 'liver transplantation in patients with cirrhosis and severe acute-on-chronic liver failure (CHANCE)': study design, demographics and overall outcome

Gustot, Thierry; (...); Jalan, Rajiv

Meeting Abstract. 2024


The ILTS-SETH Consensus Conference on Extrahepatic Cancer and Liver Transplantation: Paving the Way.

Colmenero J, Berenguer M, Watt KD

Article. 10.1097/TP.0000000000003994. 2022

  • Open Access.

The impact of COVID-19 on liver transplant (LT) centers across the world during the first wave: a Multisociety Survey (EASL-ESOT/ELITA-ILTS)

Russo, FP; (...); Polak, W

Meeting Abstract. 2021


The Impact of Direct-acting Antivirals on Overall Mortality and Tumoral Recurrence in Patients With Hepatocellular Carcinoma Listed for Liver Transplantation: An International Multicenter Study

Gorgen, A; (...); Sapisochin, G

Article. 10.1097/TP.0000000000003115. 2020


THE PRESENCE OF METABOLIC SYNDROME BEFORE TRANSPLANTATION INCREASE THE RISK OF CARDIOVASCULAR EVENTS FOLLOWING LIVER TRANSPLANTATION

Herreras, J; (...); Aguilera, V

Meeting Abstract. 2021


The Reality of Inadequate Patient Care and the Need for a Global Action Framework in Organ Donation and Transplantation.

Domínguez-Gil B; (...); Delmonico FL

Article. 10.1097/TP.0000000000004186. 2022

  • Open Access.

The role of early extubation on short-term outcomes after liver transplantation - A systematic review, meta-analysis and expert recommendations

Tinguely, Pascale; (...); ERAS4OLT Org Working Grp

Review. 10.1111/ctr.14642. 2022


The role of HBIG in real life for patients undergoing liver transplantation due to HDV-related cirrhosis

Rodriguez-Tajes, Sergio; (...); Forns, Xavier

Article. 10.1111/liv.15777. 2024

  • Open Access.

The role of preoperative optimization of the nutritional status on the improvement of short-term outcomes after liver transplantation? A review of the literature and expert panel recommendations

Victor, David W.; (...); ERAS4OLT Org Working Grp

Article. 10.1111/ctr.14647. 2022

  • Open Access.

Transaminase Pattern Over Time Is Not Associated with a More Aggressive Hepatic Evolution: Results from the AEEH Wilson Registry

Berenguer, Marina; (...); Marino, Zoe

Meeting Abstract. 2024


Transplant Oncology in Primary and Metastatic Liver Tumor: Principles, Evidence and Opportunities.

Sapisochin G; (...); Mazzaferro V

Article. 10.1097/SLA.0000000000004071. 2020


Transplantation: A Priority in the Healthcare Agenda.

Muller E; (...); Potena L

Article. 10.1097/TP.0000000000005182. 2025


Trends in liver transplantation for acute liver failure. A Spanish multicenter study

Conde, Isabel; (...); Berenguer, Marina

Meeting Abstract. 2022


Trends in liver transplantation for acute liver failure: a Spanish multicenter study

Conde, I.; (...); Berenguer, M.

Meeting Abstract. 2022


Use of HBsAg-positive donors in liver transplantation: an ILTS-EASLAASLD multisociety survey

Vinaixa, C.; (...); Terrault, N.

Meeting Abstract. 2024


Use of HBsAg-positive donors in liver transplantation: An ILTS-EASL-AASLD multisociety survey.

Vinaixa, Carmen; (...); Berenguer, Marina

Article. 10.1097/LVT.0000000000000432. 2024

  • Open Access.

Validation of MELD3.0 in 2 centers from different continents.

Tejedor M; (...); Berenguer M

Article. 10.1097/HC9.0000000000000504. 2024

  • Open Access.

Validation of MELD3.0 in two centres from different continents

Tejedor Bravo, Marta; (...); Berenguer, Marina

Meeting Abstract. 2023


Validation of MELD3.0 in two centres from different continents

Tejedor, M.; (...); Berenguer, M.

Meeting Abstract. 2023


Validation of the liver frailty index as an adverse outcome predictor in the spanish liver transplant setting. Results from a spanish multicentre prospective cohort study.

Puchades, L.; (...); Berenguer, M.

Meeting Abstract. 2023


Variation in global living donor liver transplant surgical technique - early data from the International Living Donor Liver Transplant Registry (LDLTregistry.org)

Kantsedikas, I.; (...); Rela, M.

Meeting Abstract. 2024

  • Open Access.

Variation in global living donor liver transplant surgical technique: Early data from the International Living Donor Liver Transplant Registry

Kantsedikas, Ilya; (...); Rela, Mohamed

Meeting Abstract. 10.1097/01.tp.0001066152.18661.c6. 2024

  • Open Access.

Very low access to early liver transplantation (LT) for acute alcoholic hepatitis (AAH) in a setting of social psychiatric contraindications

Garcia Garcia, S.; (...); Aguilera, V.

Meeting Abstract. 2023


Waiting time dictates impact of frailty: A Spanish multicenter prospective study.

Puchades, Lorena; (...); Berenguer, Marina

Article. 10.1016/j.jhepr.2023.100840. 2023

  • Open Access.

What is the optimal management of thromboprophylaxis after liver transplantation regarding prevention of bleeding, hepatic artery, or portal vein thrombosis? A systematic review of the literature and expert panel recommendations

Kirchner, Varvara A.; (...); ERAS4OLT Org Working Grp

Review. 2022

  • Open Access.

Wilson's Disease: Facing the Challenge of Diagnosing a Rare Disease

Sánchez-Monteagudo A; (...); Espinós C

Review. 10.3390/biomedicines9091100. 2021

  • Open Access.

Women are also disadvantaged in accessing transplant outside the United States: analysis of the spanish liver transplantation registry

Tejedor, Marta; (...); Berenguer, Marina

Meeting Abstract. 2024

  • Open Access.

Women Are Also Disadvantaged in Accessing Transplant Outside the United States: Analysis of the Spanish Liver Transplantation Registry.

Tejedor, Marta; (...); Berenguer, Marina

Article. 10.3389/ti.2024.12732. 2024

  • Open Access.

Worldwide variations in COVID-19 vaccination policies and practices in liver transplant settings: results of a multi-society global survey.

Di Maira, Tommaso; (...); Berenguer, Marina

Article. 10.3389/frtra.2023.1332616. 2023


Campos de estudio

Compartir